Conventional Surgery: Clinical Trials

239 trials of Conventional Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

152 completed, 35 unknown, 34 terminated, 10 withdrawn. 239 Phase 2, 24 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2239Completed 152, Unknown 35, Terminated 34, Withdrawn 10, Active not recruiting 7, Recruiting 1
Phase 124Completed 15, Unknown 5, Terminated 3, Withdrawn 1
Phase 33Unknown 2, Completed 1

Follow Conventional Surgery: new trials by email Literature Review of Conventional Surgery trials Research Report on Conventional Surgery

Trials (filtered) newest first · largest first

All 239 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Atezolizumab, Biospecimen Collection, Conventional Surgery - Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma
Phase 2Active not recruitingNational Cancer Institute (NCI)612022-03-112026-11-13
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement
Binimetinib, Conventional Surgery, Encorafenib - Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node
Phase 2TerminatedECOG-ACRIN Cancer Research Group32021-09-222026-10-06
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
Conventional Surgery, Dabrafenib, Intensity-Modulated Radiation Therapy - Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma
Phase 2Active not recruitingM.D. Anderson Cancer Center302021-06-242026-10-08
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma
Atezolizumab, Conventional Surgery, Fluorouracil - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2Active not recruitingM.D. Anderson Cancer Center432019-02-192026-07-28
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
Gemcitabine Hydrochloride, Cisplatin, Pegfilgrastim - Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma
Phase 2Active not recruitingAlliance for Clinical Trials in Oncology2372018-12-102026-10-16
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Capecitabine, Chemotherapy, Conventional Surgery - Gastric Adenocarcinoma, Oligometastasis
Phase 2RecruitingM.D. Anderson Cancer Center1002018-02-192026-10-06
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
Conventional Surgery, Ipilimumab, Laboratory Biomarker Analysis - Cervical Carcinoma, Esophageal Carcinoma
Phase 2WithdrawnNational Cancer Institute (NCI)2017-11-032018-10-03
Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Dasatinib, Conventional Surgery, Laboratory Biomarker Analysis - Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 2TerminatedUniversity of Wisconsin, Madison52017-05-032022-06-03
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Cetuximab, Cetuximab-IRDye 800CW, Tumor resection - Brain Neoplasm, Malignant Glioma
Phase 1 / Phase 2TerminatedEben Rosenthal32016-10-012020-03-31
Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer
Conventional Surgery, Complete mesocolic excision with central vascular ligation - Colon Cancer
Phase 2 / Phase 3UnknownMansoura University402014-09-012018-08-16
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
letrozole, MRI, conventional surgery - Breast Cancer
Phase 2CompletedAlliance for Clinical Trials in Oncology1082012-02-012018-03-27
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
Biopsy, Conventional Surgery, Genetic Testing - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Phase 2Active not recruitingM.D. Anderson Cancer Center11002011-05-312026-09-18
Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
imatinib mesylate, conventional surgery - Gastrointestinal Stromal Tumor
Phase 2CompletedPeking University202010-05-012015-02-03
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
fluorouracil, leucovorin calcium, oxaliplatin - Colorectal Cancer
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center2482008-08-012026-01-14
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
cetuximab, capecitabine, fluorouracil - Colorectal Cancer
Phase 2TerminatedUNICANCER192007-10-292020-02-11
Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
bevacizumab, capecitabine, cisplatin - Oesophagogastric Cancer
Phase 2 / Phase 3UnknownProfessor David Cunningham11032007-10-012016-12-01
Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer
Everolimus, conventional surgery - Prostate Cancer
Phase 2TerminatedJorge A. Garcia, MD172007-09-012018-12-06
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
cetuximab, cisplatin, fluorouracil - Esophageal Cancer
Phase 1 / Phase 2CompletedFederation Francophone de Cancerologie Digestive332007-07-012016-05-30
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
bevacizumab, cetuximab, fluorouracil - Colorectal Cancer, Metastatic Cancer
Phase 2UnknownCentre Hospitalier Universitaire Vaudois352007-06-012009-08-07
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
erlotinib hydrochloride, conventional surgery, immunohistochemistry staining method - Intraductal Papillary Mucinous Neoplasm of the Pancreas, Recurrent Pancreatic Cancer
Phase 2TerminatedNational Cancer Institute (NCI)62007-06-012014-10-16

Showing 20 of 239. Sign in to see all of them.

Conditions studied

Breast Neoplasms (30)  ·  Colorectal Neoplasms (24)  ·  Central Nervous System Neoplasms (23)  ·  Rectal Neoplasms (23)  ·  Esophageal Neoplasms (21)  ·  Sarcoma (19)  ·  Adenocarcinoma Of Esophagus (18)  ·  Carcinoma, Non-Small-Cell Lung (18)  ·  Lung Neoplasms (18)  ·  Colonic Neoplasms (17)  ·  Glioblastoma (17)  ·  Brain Neoplasms (16)  ·  Gliosarcoma (16)  ·  Head and Neck Neoplasms (16)  ·  Neoplasm Metastasis (16)

Sponsors

National Cancer Institute (NCI) (17)  ·  European Organisation for Research and Treatment of Cancer - EORTC (11)  ·  Memorial Sloan Kettering Cancer Center (11)  ·  M.D. Anderson Cancer Center (10)  ·  Radiation Therapy Oncology Group (10)  ·  Children's Oncology Group (9)  ·  Roswell Park Cancer Institute (8)  ·  SWOG Cancer Research Network (8)  ·  Alliance for Clinical Trials in Oncology (7)  ·  Case Comprehensive Cancer Center (6)  ·  Children's Cancer and Leukaemia Group (5)  ·  City of Hope Medical Center (5)  ·  Fox Chase Cancer Center (4)  ·  GERCOR - Multidisciplinary Oncology Cooperative Group (4)  ·  Jonsson Comprehensive Cancer Center (4)

Countries

United States (177)  ·  Canada (22)  ·  United Kingdom (19)  ·  France (18)  ·  Switzerland (14)  ·  Belgium (13)  ·  Australia (10)  ·  Netherlands (10)  ·  Italy (9)  ·  Germany (8)  ·  Puerto Rico (8)  ·  Austria (6)  ·  Spain (6)  ·  Sweden (6)  ·  Ireland (4)

Top investigators

A. Bapsi Chakravarthy, MD (2)  ·  Aminah Jatoi, MD (2)  ·  Burton L. Eisenberg, MD (2)  ·  Colin P. Dinney, MD (2)  ·  David Cunningham, MD (2)  ·  David J. Adelstein, MD (2)  ·  David J. Perry, MD (2)  ·  David Paul Kelsen, MD (2)  ·  Frank Berthold, MD (2)  ·  Gene David Resnick, MD (2)  ·  Jeffry Alger, PhD (2)  ·  Kevin G. Billingsley, MD (2)  ·  Lawrence P. Leichman, MD (2)  ·  Merrill S. Kies, MD (2)  ·  Paul A. Meyers, MD (2)

Results publications

PMID 25057165, PMID 11241082, PMID 11857322, PMID 11904735, PMID 14508361, PMID 14520092, PMID 14673042, PMID 15533252, PMID 15565574, PMID 15646530, PMID 15999362, PMID 16116597, PMID 16200343, PMID 16382125, PMID 16399443, PMID 16446334, PMID 16446336, PMID 16624554, PMID 16826357, PMID 16921048, PMID 17030548, PMID 17235046, PMID 17429100, PMID 17761982, PMID 17921712, PMID 17947728, PMID 18191528, PMID 18270337, PMID 18418009, PMID 18565686, PMID 18645482, PMID 18783876, PMID 18845990, PMID 18942073, PMID 19100600, PMID 19171715, PMID 19604722, PMID 19720915, PMID 19770418, PMID 19816190, PMID 19917840, PMID 20461765, PMID 20525721, PMID 20572040, PMID 20576718, PMID 20975604, PMID 21135251, PMID 21156335, PMID 21172879, PMID 21205757

NIH funding

P30CA043703 (8), U10CA032102 (8), P30CA033572 (6), P30CA006927 (4), P30CA016672 (4), P30CA006973 (3), U10CA098543 (3), U10CA180821 (3), 2004 (2), P30CA015083 (2), P30CA021765 (2), P30CA036727 (2), U10CA021115 (2), U10CA025224 (2), U10CA027469 (2)